Ardent Health (NYSE:ARDT) Releases FY 2025 Earnings Guidance

Key Points

• Ardent Health updated its FY 2025 earnings guidance with an EPS range of 1.730-2.01, slightly below the consensus estimate of 1.914, and revenue guidance of $6.2 billion-$6.5 billion, compared to a consensus of $6.3 billion.
• The stock experienced a 3.6% increase in trading, closing at $10.68, with a market cap of $1.53 billion and a price-to-earnings ratio of 6.55.
• Brokerage ratings vary, with one analyst issuing a sell, one a hold, while ten gave buy ratings, and two issued strong buy ratings, leading to a consensus rating of "Moderate Buy" with a target of $20.30.

Ardent Health (NYSE:ARDT - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.730-2.01 for the period, compared to the consensus estimate of 1.914. The company issued revenue guidance of $6.2 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

Ardent Health Trading Up 1.9%

Shares of ARDT traded up $0.22 during trading hours on Friday, reaching $11.69. The stock had a trading volume of 176,739 shares, compared to its average volume of 404,442. Ardent Health has a 52 week low of $10.10 and a 52 week high of $20.72. The firm has a 50-day moving average of $12.73 and a 200 day moving average of $13.49. The company has a market cap of $1.67 billion and a P/E ratio of 6.46. The company has a quick ratio of 1.98, a current ratio of 2.12 and a debt-to-equity ratio of 0.70.

Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.30 by $0.22. The business had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 17.10%. On average, sell-side analysts expect that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. KeyCorp reduced their price objective on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research note on Thursday. Wall Street Zen lowered Ardent Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, July 12th. Stephens reaffirmed an "overweight" rating and set a $21.00 price objective on shares of Ardent Health in a research report on Tuesday, May 20th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $21.00 price target on shares of Ardent Health in a research note on Thursday, May 15th. Finally, Bank of America cut shares of Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the stock from $15.50 to $14.60 in a research report on Wednesday, July 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.97.

Hedge Funds Weigh In On Ardent Health

Several institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC raised its position in Ardent Health by 0.6% in the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock worth $3,918,000 after acquiring an additional 1,769 shares during the period. Acadian Asset Management LLC lifted its stake in shares of Ardent Health by 574.9% during the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company's stock valued at $550,000 after buying an additional 34,276 shares in the last quarter. Jane Street Group LLC boosted its holdings in Ardent Health by 235.1% in the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company's stock worth $790,000 after buying an additional 40,318 shares during the period. Goldman Sachs Group Inc. raised its holdings in Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock valued at $10,558,000 after acquiring an additional 724,841 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Ardent Health by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company's stock worth $194,000 after acquiring an additional 7,182 shares in the last quarter.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.